Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only
Online Services

I-TASSER I-TASSER-MTD C-I-TASSER CR-I-TASSER QUARK C-QUARK LOMETS MUSTER CEthreader SEGMER DeepFold DeepFoldRNA FoldDesign COFACTOR COACH MetaGO TripletGO IonCom FG-MD ModRefiner REMO DEMO DEMO-EM DMFold SPRING COTH Threpp PEPPI BSpred ANGLOR EDock BSP-SLIM SAXSTER FUpred ThreaDom ThreaDomEx EvoDesign BindProf BindProfX SSIPe GPCR-I-TASSER MAGELLAN ResQ STRUM DAMpred

TM-score TM-align US-align MM-align RNA-align NW-align LS-align EDTSurf MVP MVP-Fit SPICKER HAAD PSSpred 3DRobot MR-REX I-TASSER-MR SVMSEQ NeBcon ResPRE TripletRes DeepPotential WDL-RF ATPbind DockRMSD DeepMSA FASPR EM-Refiner GPU-I-TASSER

BioLiP E. coli GLASS GPCR-HGmod GPCR-RD GPCR-EXP Tara-3D TM-fold DECOYS POTENTIAL RW/RWplus EvoEF HPSF THE-DB ADDRESS Alpaca-Antibody CASP7 CASP8 CASP9 CASP10 CASP11 CASP12 CASP13 CASP14

You can:

GPCR

NameHydroxycarboxylic acid receptor 2
SpeciesHomo sapiens (Human)
GeneHCAR2
SynonymG protein-coupled receptor 109A
PUMAG
Nicotinic acid receptor
Nic1
Niacr1
[ Show all ]
DiseaseType 2 diabetes
Hyperlipidaemia
Major depressive disorder
Cardiovascular disorder
Atherosclerosis
[ Show all ]
Length363
Amino acid sequenceMNRHHLQDHFLEIDKKNCCVFRDDFIVKVLPPVLGLEFIFGLLGNGLALWIFCFHLKSWKSSRIFLFNLAVADFLLIICLPFLMDNYVRRWDWKFGDIPCRLMLFMLAMNRQGSIIFLTVVAVDRYFRVVHPHHALNKISNRTAAIISCLLWGITIGLTVHLLKKKMPIQNGGANLCSSFSICHTFQWHEAMFLLEFFLPLGIILFCSARIIWSLRQRQMDRHAKIKRAITFIMVVAIVFVICFLPSVVVRIRIFWLLHTSGTQNCEVYRSVDLAFFITLSFTYMNSMLDPVVYYFSSPSFPNFFSTLINRCLQRKMTGEPDNNRSTSVELTGDPNKTRGAPEALMANSGEPWSPSYLGPTSP
UniProtQ8TDS4
Protein Data BankN/A
GPCR-HGmod modelQ8TDS4
3D structure modelThis predicted structure model is from GPCR-EXP Q8TDS4.
BioLiPN/A
Therapeutic Target DatabaseT00864
ChEMBLCHEMBL3785
IUPHAR312
DrugBankBE0000635

Ligand

Namenicotinic acid
Molecular formulaC6H5NO2
IUPAC namepyridine-3-carboxylic acid
Molecular weight123.111
Hydrogen bond acceptor3
Hydrogen bond donor1
XlogP0.4
SynonymsCS-1946
3-Carboxylpyridine
Diacin
3-Pyridylcarboxylic acid
EC 200-441-0
[ Show all ]
Inchi KeyPVNIIMVLHYAWGP-UHFFFAOYSA-N
Inchi IDInChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)
PubChem CID938
ChEMBLCHEMBL573
IUPHAR1588, 1594
BindingDB23515
DrugBankDB00627

Structure

SDF download

2D structure
Lipinski's druglikenessThis ligand satisfies Lipinski's rule of five.

Experimental Data

ParameterValueReferenceDatabase source
N/A N/ADrugBank
Activity100.0 %PMID18752940, PMID19592242ChEMBL
Activity200.0 %PMID19524438ChEMBL
EC50<1000.0 nMPMID17804224ChEMBL
EC508.7 nMPMID17804224BindingDB
EC508.71 nMPMID17804224ChEMBL
EC5026.92 nMPMID19524438ChEMBL
EC5027.0 nMPMID20363624, PMID19524438BindingDB,ChEMBL
EC5047.0 nMPMID25737085ChEMBL
EC5051.0 nMPMID22435740BindingDB,ChEMBL
EC5063.1 - 1000.0 nMPMID12522134, PMID12563315, PMID12646212IUPHAR
EC5099.0 nMPMID24900372BindingDB,ChEMBL
EC50100.0 nMPMID24900295, PMID22209457BindingDB,ChEMBL
EC50120.0 nMPMID17358052, PMID17588745BindingDB,ChEMBL
EC50527.0 nMPMID20184326BindingDB,ChEMBL
EC50580.0 nMPMID17452318BindingDB,ChEMBL
EC50730.0 nMPMID26784936BindingDB,ChEMBL
EC50780.0 nMPMID24900524BindingDB,ChEMBL
EC501000.0 nMPMID17994679, PMID20444602, PMID19309152, PMID18029181, PMID18752940, PMID19592242, PMID20452209BindingDB,ChEMBL
EC501400.0 nMPMID18760600BindingDB,ChEMBL
Efficacy95.0 %PMID17804224, PMID22435740ChEMBL
Efficacy100.0 %PMID20363624ChEMBL
Fold change0.0 -PMID17994679ChEMBL
IC50130.0 nMPMID18760600BindingDB,ChEMBL
IC50140.0 nMPMID17994679, PMID20444602, PMID19307116, PMID20615702, PMID19309152, PMID18029181, PMID19592242, PMID20452209BindingDB,ChEMBL
IC50150.0 nMPMID18752940BindingDB,ChEMBL
IC50249.0 nMPMID25737085ChEMBL
IC5067300.0 nMPMID17452318BindingDB,ChEMBL
Inhibition100.0 %PMID17452318ChEMBL
Kd50.1 - 100.0 nMPMID12522134, PMID12563315, PMID12646212IUPHAR
Ki50.0 nMPMID18665582BindingDB,ChEMBL
Ki82.0 nMPMID20184326BindingDB,ChEMBL
Ki104.0 nMPMID20184326BindingDB,ChEMBL
Ratio0.8 -PMID25737085ChEMBL
Ratio IC500.0 -PMID19309152ChEMBL

zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218